Drug Chatter -- Tracking biopharma stock chatter

Profile for MacroGenics, Inc. (MGNX)

« Back to company index

MGNX Chatter Timeline

Stock Ticker for MGNX

Most Active Tweeters for MGNX

UserTweets
@JasonHolman5 7
@biotech_sector 6
@TickerReport 4
@storminvestor 3
@TheMarketsDaily 3

Recent Tweets for MGNX

InsiderAlertsIA @InsiderAlertsIA
$MGNX: New Insider Filing on Sr VP, Research & CSO EZIO BONVINI: https://t.co/jqXHbY5HNi
July 27th 2017, 5:07pm
biotech_sector @biotech_sector
#MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call . Read more: https://t.co/TUG2v9Ve4p $MGNX
July 27th 2017, 3:07pm
biotech_sector @biotech_sector
#MacroGenics Announces Date Of Second Quarter 2017 Financial Results Conference Call . Read more: https://t.co/FKfVCZOmA3 $MGNX
July 27th 2017, 12:07pm
biotech_sector @biotech_sector
#MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call. Read more: https://t.co/XIG6Np3Lk7 $MGNX
July 26th 2017, 4:07pm
stockboardinc @stockboardinc
$MGNX MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call... - https://t.co/vlwA1Iwfu2
July 26th 2017, 4:07pm
newswelldone @newswelldone
$MGNX: MacroGenics Announces Date of Second Quarter 2017 Financial …: https://t.co/D3kW8Ce7pP
July 26th 2017, 4:07pm
GNWLive @GNWLive
MacroGenics Announces Date of Second Quarter 2017 Financial Results Conference Call $MGNX https://t.co/pYq6NKnyls
July 26th 2017, 4:07pm
JasonHolman5 @JasonHolman5
Took on the risk w/burn rate into ER, final $MGNX & overall bio port. add for the month; added 15% to pos., cost avg now $17.30.
July 26th 2017, 10:07am
wboscoho @wboscoho
“please sir*, anytime U are ready!” * $MGNX https://t.co/MPCMHI0P84
July 25th 2017, 2:07pm
finboxio @finboxio
Our MacroGenics, $MGNX fundamental analysis highlights stock's 10% undervalued b4 earnings next Tuesday… https://t.co/a7O5LTqeaf
July 25th 2017, 8:07am
intercooleronli @intercooleronli
MacroGenics, Inc. $MGNX Given Consensus Rating of “Buy” by Brokerages https://t.co/bWRo6IoFUi
July 24th 2017, 5:07pm
SleekMoneycom @SleekMoneycom
MacroGenics, Inc. $MGNX Receives Consensus Rating of “Buy” from Brokerages https://t.co/jkCL8HGfza
July 24th 2017, 5:07pm
kodak_wong @kodak_wong
which buyside firm told @ZacksResearch to issue a sell on $mgnx https://t.co/CcRAzIfwYa
July 24th 2017, 3:07pm
storminvestor @storminvestor
Principal Financial Group Inc. Decreases Stake in MacroGenics, Inc. $MGNX https://t.co/Y2TG5WNfSH
July 23rd 2017, 9:07am
intercooleronli @intercooleronli
MacroGenics, Inc. $MGNX Expected to Announce Quarterly Sales of $4.62 Million https://t.co/0ewUuA0uvi
July 23rd 2017, 8:07am
WKRBNews @WKRBNews
MacroGenics, Inc. $MGNX Lifted to “Hold” at Zacks Investment Research https://t.co/a1KXhhKdsq
July 22nd 2017, 7:07am
WKRBNews @WKRBNews
MacroGenics, Inc. $MGNX Lifted to “Hold” at Zacks Investment Research https://t.co/4Qo0KAumoC
July 22nd 2017, 7:07am
WatchlistN @WatchlistN
MacroGenics, Inc. $MGNX Lifted to “Hold” at Zacks Investment Research https://t.co/ARvssL9zFo
July 22nd 2017, 7:07am
JasonHolman5 @JasonHolman5
https://t.co/ow85EHvEHM $MGNX MGAH22 PH3 trial minor update; recruiting sites increased from 186 to 197.
July 21st 2017, 5:07pm
IRAMarketReport @IRAMarketReport
MacroGenics, Inc. $MGNX Raised to Hold at Zacks Investment Research https://t.co/Zdai69fUDc
July 21st 2017, 4:07pm
chaffeybreeze @chaffeybreeze
MacroGenics, Inc. $MGNX Raised to Hold at Zacks Investment Research https://t.co/AT25zf67nr
July 21st 2017, 4:07pm
JasonHolman5 @JasonHolman5
Of course risky as $MGNX still needs to prove their trials issues are resolved&unlock some value from their MGD010 asset.
July 21st 2017, 12:07pm
JasonHolman5 @JasonHolman5
Small add to $MGNX down here,? is there is an opp based upon data maturing; starting w/MGD006 oral pres.&then the MGAH22&MGA271 combo trials
July 21st 2017, 12:07pm
dogeofbaystreet @dogeofbaystreet
buying more $MGNX
July 21st 2017, 11:07am
JasonHolman5 @JasonHolman5
RT @LSinnv: @JasonHolman5 Some cheer on the $MGNX B7H3 front: y-mabs recently got breathrough on MSK's drug targeting neuroblastoma https:/…
July 21st 2017, 10:07am
JasonHolman5 @JasonHolman5
@LSinnv Great find??, assists in further validating $MGNX continued focus on B7-H3&their mono. trial in pediatric p… https://t.co/quvIPsX3Tn
July 21st 2017, 10:07am
LSinnv @LSinnv
@JasonHolman5 Some cheer on the $MGNX B7H3 front: y-mabs recently got breathrough on MSK's drug targeting neuroblas… https://t.co/4YeidbN8WI
July 21st 2017, 8:07am
dogeofbaystreet @dogeofbaystreet
Long $MGNX I am buying some more. Going on vacation and I won't even be worried about this investment.
July 20th 2017, 3:07pm
TheMarketsDaily @TheMarketsDaily
MacroGenics, Inc. $MGNX Position Cut by JPMorgan Chase & Co. https://t.co/hDaFjMBvZa
July 20th 2017, 1:07pm
storminvestor @storminvestor
MacroGenics, Inc. $MGNX Upgraded to Hold by Zacks Investment Research https://t.co/kHtJGsQq0w
July 20th 2017, 10:07am
SPNewsAnalysis @SPNewsAnalysis
MacroGenics, Inc. $MGNX Upgraded to Hold by Zacks Investment Research https://t.co/LiJEMuC95s
July 20th 2017, 10:07am
dakotafinancial @dakotafinancial
MacroGenics, Inc. $MGNX Stock Rating Upgraded by Zacks Investment Research https://t.co/k4JdT43Us6
July 20th 2017, 9:07am
SleekMoneycom @SleekMoneycom
MacroGenics, Inc. $MGNX Position Raised by American International Group Inc. https://t.co/UJhUCLM8Zp
July 20th 2017, 8:07am
SPNewsAnalysis @SPNewsAnalysis
MacroGenics $MGNX Receiving Somewhat Favorable Press Coverage, Report Finds https://t.co/Re8tStfP8x
July 19th 2017, 4:07pm
storminvestor @storminvestor
MacroGenics $MGNX Receiving Somewhat Favorable Press Coverage, Report Finds https://t.co/Fd9RpgoIib
July 19th 2017, 4:07pm
WatchlistN @WatchlistN
MacroGenics $MGNX Receiving Somewhat Favorable Press Coverage, Report Finds https://t.co/10BHQgUXEW
July 19th 2017, 1:07pm
1stOncology @1stOncology
Interim Results from a Phase 1 FIH Study of #Flotetuzumab in AML/MDS at #ESMO2017 $MGNX https://t.co/oxke90Cq2U
July 19th 2017, 12:07pm
TheMarketsDaily @TheMarketsDaily
SG Americas Securities LLC Decreases Position in MacroGenics, Inc. $MGNX https://t.co/g7xnpWRSSj
July 19th 2017, 9:07am
JasonHolman5 @JasonHolman5
$MGNX another w/HIGH 82% tutes(64% stock),but only 1.6% insiders(most held by CEO). Still only 11.3% other or "reta… https://t.co/WkHuZ43c7j
July 18th 2017, 8:07pm
dailymailtimes @dailymailtimes
MacroGenics, Inc. $MGNX Stock Rating Upgraded by Zacks Investment Research https://t.co/IEweM7h7RS
July 18th 2017, 7:07am
TickerReport @TickerReport
MacroGenics, Inc. $MGNX Shares Sold by Bank of New York Mellon Corp https://t.co/EyxKedhH19
July 18th 2017, 4:07am
emq_news @emq_news
MacroGenics, Inc. $MGNX Shares Sold by Bank of New York Mellon Corp https://t.co/LATlh7tBNW
July 18th 2017, 4:07am
TickerReport @TickerReport
MacroGenics, Inc. $MGNX Shares Sold by Bank of New York Mellon Corp https://t.co/D7l7ukBgKm
July 18th 2017, 4:07am
RatingsNetwork @RatingsNetwork
MacroGenics upgraded by Zacks Investment Research to hold. https://t.co/O0dlFhTJSB $MGNX #MGNX
July 18th 2017, 1:07am
biotech_sector @biotech_sector
Phase 1 Data for Flotetuzumab, #MacroGenics' CD123 x CD3 DART® Molecule, Accepted for Oral ... Read more: https://t.co/2VHbsaLjyP $MGNX
July 17th 2017, 10:07pm
biotech_sector @biotech_sector
Phase 1 Data for Flotetuzumab, #MacroGenics' CD123 x CD3 DART® Molecule, Accepted for Oral ... Read more: https://t.co/MD4xFUZURr $MGNX
July 17th 2017, 8:07pm
biotech_sector @biotech_sector
Phase 1 Data for Flotetuzumab, #MacroGenics' CD123 x CD3 DART� Molecule, Accepted for Ora... Read more: https://t.co/WnTIvJQmCk $MGNX
July 17th 2017, 8:07pm
MDDailyRecord @MDDailyRecord
A Maryland biopharmaceutical firm’s research data has been accepted for an oral presentation in Europe. https://t.co/UnKUmcyMn8 $MGNX
July 17th 2017, 10:07am
BlackHawkTrader @BlackHawkTrader
Bought $MGNX starter at 17.78
July 17th 2017, 9:07am
ProVesting @ProVesting
$MGNX: Macrogenics (MGNX) Says Phase 1 Data for Flotetuzumab, CD123 …: https://t.co/NfoXtfP3aS
July 17th 2017, 9:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.